Effect of atorvastatin on C-reactive protein and benefits for cardiovascular disease in patients with type 2 diabetes: analyses from the Collaborative Atorvastatin Diabetes Trial

AIMS/HYPOTHESIS: We investigated whether atorvastatin 10 mg daily lowered C-reactive protein (CRP) and whether the effects of atorvastatin on cardiovascular disease (CVD) varied by achieved levels of CRP and LDL-cholesterol. METHODS: CRP levels were measured at baseline and 1 year after randomisatio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetologia
Main Authors: Soedamah-Muthu, Sabita S., Livingstone, Shona J., Charlton-Menys, Valentine, Betteridge, D. John, Hitman, Graham A., Neil, H. Andrew W., Bao, Weihang, DeMicco, David A., Preston, Gregory M., Fuller, John H., Stehouwer, Coen D. A., Schalkwijk, Casper G., Durrington, Paul N., Colhoun, Helen M.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4472939/
https://ncbi.nlm.nih.gov/pubmed/25899452
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00125-015-3586-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados